26 February 2025
26 February 2025
GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
Fresenius Medical Care raised its 2025 savings target on the back of divested assets in 2024.
OrganOx's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.
The system’s availability for current and new US customers is anticipated by next month.
The dosing procedures were performed at early adopter imaging centres across the US.
Having posted triple-digit growth over recent years, the company aims to enter its perfusion mapping software into new markets.
The company's submission includes a request to approve the system for all indications currently authorised for its ProSense system.
Cubbie’s multisensory spaces are designed to help neurodivergent individuals manage their conditions.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
